Product NDC: | 50458-170 |
Proprietary Name: | LEVAQUIN |
Non Proprietary Name: | levofloxacin |
Active Ingredient(s): | 25 mg/mL & nbsp; levofloxacin |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50458-170 |
Labeler Name: | Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021721 |
Marketing Category: | NDA |
Start Marketing Date: | 20041021 |
Package NDC: | 50458-170-01 |
Package Description: | 480 mL in 1 BOTTLE (50458-170-01) |
NDC Code | 50458-170-01 |
Proprietary Name | LEVAQUIN |
Package Description | 480 mL in 1 BOTTLE (50458-170-01) |
Product NDC | 50458-170 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levofloxacin |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20041021 |
Marketing Category Name | NDA |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | LEVOFLOXACIN |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |